Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
125.89
+0.45 (+0.36%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
69
70
Next >
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
With the COVID pandemic still ongoing, having claimed more than 6.8 million lives from about 758 million cases and crippling the global economy, there are several reasons why drug research and...
Via
Benzinga
Could This Be Merck's Next Blockbuster Drug?
March 18, 2023
Merck recently shared encouraging clinical trial results for its cholesterol-lowering drug candidate.
Via
The Motley Fool
This High-Growth Company Is Expanding. Time to Buy the Stock?
March 16, 2023
Moderna shares have lost about 15% so far this year.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
March 16, 2023
Via
Benzinga
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
March 14, 2023
Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr.
Via
Benzinga
A Look Into Merck & Co's Debt
March 10, 2023
Via
Benzinga
Expert Ratings for Merck & Co
March 10, 2023
Via
Benzinga
Peering Into Merck & Co's Recent Short Interest
March 09, 2023
Via
Benzinga
Why OPKO Health Shares Jumped on Wednesday
March 08, 2023
A major pharma name is showing interest in one of the company's vaccine prospects.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
March 13, 2023
Via
Benzinga
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
March 13, 2023
After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis.
Via
Benzinga
Merck Highlights Promising Data From Two Candidates In Heart Diseases
March 06, 2023
Via
Benzinga
Merck Discontinues Two Keytruda Combo Therapy Trials In Prostate & Lung Cancer Settings
February 28, 2023
Via
Benzinga
Stock Market Tumbles Amid SVB Financial Collapse, 'Faster' Powell: Weekly Review
March 10, 2023
The major indexes suffered serious losses this past week.
Via
Investor's Business Daily
Merck's Keytuda+Chemo Combo Improves Overall Survival In Patients With Advanced Mesothelioma
March 10, 2023
Merck & Co Inc (NYSE: MRK) announced that the Phase 2/3 CCTG IND.227/KEYNOTE-483 trial of Keytruda plus chemotherapy combo met its primary endpoint in unresectable advanced or metastatic malignant...
Via
Benzinga
United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday
March 10, 2023
Piper Sandler raised the price target for Riskified Ltd. (NYSE: RSKD) from $6 to $8. Piper Sandler analyst Brent Bracelin upgraded the stock from Neutral to Overweight. Riskified shares rose 2.4% to...
Via
Benzinga
Dividend Stocks Alert: 10 Top Holdings From the SCHD ETF
March 08, 2023
Dividend funds like the SCHD ETF are gaining traction ahead of its March 27 dividend payment. What are the top 10 holdings in the ETF?
Via
InvestorPlace
OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck
March 08, 2023
Via
Benzinga
2 Top Healthcare Stocks to Buy Right Now
March 08, 2023
Most people eventually need the healthcare goods/services that these companies provide.
Via
The Motley Fool
Beat the Dow Jones With This Unstoppable Dividend Stock
March 08, 2023
Merck had a strong year and has the portfolio and pipeline to increase its dividend.
Via
The Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
Via
Benzinga
Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success
March 07, 2023
Via
Benzinga
Keytruda Who? Merck Nears Breakout On $10 Billion Sales Potential For Heart Drugs
March 07, 2023
The heart segment is becoming more important as Keytruda near patent expiration.
Via
Investor's Business Daily
DocuSign To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday
March 07, 2023
Wells Fargo cut the price target for Cheniere Energy, Inc. (NYSE: LNG) from $236 to $230. Wells Fargo analyst Michael Blum maintained an Overweight rating. Cheniere Energy shares fell 4.8% to close at...
Via
Benzinga
Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading
March 06, 2023
Over the past week, the market had a nice uptick making it harder for defensive sectors like healthcare to get traction up only 0.51% and down almost 5% YTD.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023
March 06, 2023
Via
Benzinga
Secrets Of Great Long-Term Stock Investors
March 05, 2023
What can the rest of us learn from Warren Buffett's long-term stock buys? Here are 5 stock ideas for long-term investors.
Via
Talk Markets
Week In Review: Abbisko Out-Licenses Rights To Precision NSCLC Medicine For $188 Million
March 04, 2023
Abbisko Therapeutics out-licensed Greater China rights to a pre-clinical EGFR-TKI candidate for NSCLC to Allist Pharma in a $188 million deal. Also, Chipscreen Bio acquired greater China rights to a...
Via
Talk Markets
After Shelving Two Keytruda Trials, Merck Touts Encouraging Data From Keytuda Regime Study In Lung Cancer Patients
March 01, 2023
Via
Benzinga
Why Compugen Shares Are Up Today
February 28, 2023
The company released its fourth-quarter and full-year results after the bell Monday.
Via
The Motley Fool
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.